Загрузка...
Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using a IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex
Bispecific antibodies (BsAb) have proven to be useful targeting vectors for pretargeted radioimmunotherapy (PRIT). We sought to overcome key PRIT limitations such as high renal radiation exposure and immunogenicity (e.g. of streptavidin-antibody fusions), to advance clinical translation of this PRIT...
Сохранить в:
Опубликовано в: : | Mol Cancer Ther |
---|---|
Главные авторы: | , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
2014
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221074/ https://ncbi.nlm.nih.gov/pubmed/24944121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0933 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|